MTOR and type 2 diabetes mellitus: Most studies have demonstrated lower autophagy activity in cardiomyocytes of type 1 and type 2 diabetes due to activated mammalian target of rapamycin(mTOR) and inhibited AMPK and transcription factor EB(TFEB) signalling in diabetic hearts.27, 28